Video interview with this patient with childhood asthma and ABPA. After persistent chest infections and continuous steroids and a bad productive cough, Aspergillus was cultured from sputum in 2002. After successfully taking itraconazole, the patient developed peripheral neuropathy (tingling and loss of sensation) in the hands. After stopping itraconazole – persistent chest infections requiring antibiotics and prednisolone were common. The patient at this point had a high IgE level and positive RAST tests. Voriconazole was then prescribed – which has successfully treated the aspergillus infection – no steroids are required and the cough is greatly reduced with the patient feeling well. However an unfortunate side effect of voriconazole has been a photosensitive rash on any exposed skin. Despite using complete sunscreen – the rash continues. The patient is continuing to take voriconazole.
Share this post
Latest News posts
Spring COVID Booster
March 8, 2023
Accessing GP services
March 8, 2023
NAC CARES Virtual Challenge – Week 2
February 17, 2023
NAC CARES Virtual Challenge – Week 1
February 10, 2023
NAC CARES team charity run for the Fungal Infection Trust
January 31, 2023
Diagnosis
December 2, 2022
Loneliness and Aspergillosis
November 30, 2022
Doing a disability assessment
November 21, 2022
Finding an advocate
November 21, 2022
News archive
- Antifungals in development
- COVID-19
- Events
- Fundraising
- General interest
- How do I...?
- Information and Learning
- Latest research news
- Lifestyle and Coping Skills
- Living with Aspergillosis
- NAC announcements
- News archive
- Patient and Carer Blog
- Patient stories
- Recordings
- Supplements and complementary therapies
- Types of aspergillosis
- Video